Monitor for COVID-19 vaccine resistance evolution during clinical trials

Kennedy, David A. and Read, Andrew F. (2020) Monitor for COVID-19 vaccine resistance evolution during clinical trials. PLOS Biology, 18 (11). e3001000. ISSN 1545-7885

[thumbnail of file_id=10.1371%2Fjournal.pbio.3001000&type=printable] Text
file_id=10.1371%2Fjournal.pbio.3001000&type=printable - Published Version
Download (572kB)

Abstract

Although less common than the evolution of antimicrobial drug resistance, vaccine resistance can and has evolved. How likely is it that COVID-19 vaccines currently in development will be undermined by viral evolution? We argue that this can be determined by repurposing samples that are already being collected as part of clinical trials. Such information would be useful for prioritizing investment among candidate vaccines and maximizing the potential long-term impact of COVID-19 vaccines.

Item Type: Article
Subjects: OA Digital Library > Biological Science
Depositing User: Unnamed user with email support@oadigitallib.org
Date Deposited: 07 Jan 2023 09:27
Last Modified: 02 May 2024 05:42
URI: http://library.thepustakas.com/id/eprint/16

Actions (login required)

View Item
View Item